logo
Book a meeting
Repair Biotechnologies

Repair Biotechnologies

Biotechnology, 841 E Fayette St, Syracuse, New York, 13210, United States, 1-10 Employees

repairbiotechnologies.com

  • LinkedIn

phone no Phone Number: 12***********

Who is REPAIR BIOTECHNOLOGIES

Repair Biotechnologies is a preclinical biotechnology company focused on developing drugs for cholesterol and aging-related diseases. Our first-in-class Cholesterol Degrading Platform (CD...

Read More

lock icon Get Full Access
map
  • 841 E Fayette St, Syracuse, New York, 13210, United States Headquarters: 841 E Fayette St, Syracuse, New York, 13210, United States
  • 2018 Date Founded: 2018
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

checked-icon Does something look wrong? Fix it. | View contact records from REPAIR BIOTECHNOLOGIES

Repair Biotechnologies Org Chart and Mapping

Employees
Ian Laih

Ian Laih

Associate Scientist

Iyan Warren

Iyan Warren

Scientist 2

Garrett Strough

Garrett Strough

Scientist II

See Full Org Chart arrow
email-formate-icon
View Email Formats for Repair Biotechnologies
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding Repair Biotechnologies

Answer: Repair Biotechnologies's headquarters are located at 841 E Fayette St, Syracuse, New York, 13210, United States

Answer: Repair Biotechnologies's phone number is 12***********

Answer: Repair Biotechnologies's official website is https://repairbiotechnologies.com

Answer: Repair Biotechnologies's revenue is Under $1 Million

Answer: Repair Biotechnologies has 1-10 employees

Answer: Repair Biotechnologies is in Biotechnology

Answer: Repair Biotechnologies contact info: Phone number: 12*********** Website: https://repairbiotechnologies.com

Answer: Repair Biotechnologies is a preclinical biotechnology company focused on developing drugs for cholesterol and aging-related diseases. Our first-in-class Cholesterol Degrading Platform (CDP) technology is aimed at reversing atherosclerosis, familial hypercholesterolemias, and other conditions in which excess or modified cholesterol drives pathology.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access